(HXL) Hexcel - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US4282911084
Stock: Carbon Fiber, Honeycomb, Prepregs, Composites, Adhesives
Total Rating 69
Risk 98
Buy Signal 1.34
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.12% |
| Yield on Cost 5y | 1.42% |
| Yield CAGR 5y | 19.35% |
| Payout Consistency | 35.6% |
| Payout Ratio | 39.2% |
| Risk 5d forecast | |
|---|---|
| Volatility | 29.8% |
| Relative Tail Risk | -1.08% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.92 |
| Alpha | 19.16 |
| Character TTM | |
|---|---|
| Beta | 1.062 |
| Beta Downside | 1.132 |
| Drawdowns 3y | |
|---|---|
| Max DD | 38.18% |
| CAGR/Max DD | 0.22 |
Description: HXL Hexcel January 10, 2026
Hexcel Corporation (NYSE:HXL) designs, manufactures, and markets carbon-fiber composites, honeycomb structures, resins, and related parts for commercial aerospace, space & defense, and industrial markets, operating through two segments: Composite Materials and Engineered Products.
Key metrics: FY 2023 revenue reached roughly $2.0 billion with an operating margin near 8%; the company reported a backlog of about $3.5 billion, indicating strong order flow. Growth drivers include rising jet-liner deliveries (projected 3-4 % CAGR through 2028), expanding wind-turbine blade demand, and sustained U.S. defense spending that supports high-performance composite applications. Raw-material cost volatility-particularly for polyacrylonitrile (PAN) precursors-remains a material-price risk that Hexcel manages through long-term supply contracts.
For a deeper, data-driven view of Hexcel’s valuation and risk profile, you might explore the analyst tools on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 109.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA -1.53 > 1.0 |
| NWC/Revenue: 21.54% < 20% (prev 22.49%; Δ -0.95% < -1%) |
| CFO/TA 0.09 > 3% & CFO 230.5m > Net Income 109.4m |
| Net Debt (922.0m) to EBITDA (293.8m): 3.14 < 3 |
| Current Ratio: 2.26 > 1.5 & < 3 |
| Outstanding Shares: last quarter (77.6m) vs 12m ago -5.25% < -2% |
| Gross Margin: 22.96% > 18% (prev 0.25%; Δ 2271 % > 0.5%) |
| Asset Turnover: 69.76% > 50% (prev 69.81%; Δ -0.05% > 0%) |
| Interest Coverage Ratio: 4.58 > 6 (EBITDA TTM 293.8m / Interest Expense TTM 37.7m) |
Altman Z'' 5.86
| A: 0.15 (Total Current Assets 730.7m - Total Current Liabilities 322.7m) / Total Assets 2.70b |
| B: 0.85 (Retained Earnings 2.31b / Total Assets 2.70b) |
| C: 0.06 (EBIT TTM 172.7m / Avg Total Assets 2.71b) |
| D: 1.58 (Book Value of Equity 2.30b / Total Liabilities 1.45b) |
| Altman-Z'' Score: 5.86 = AAA |
Beneish M -4.00
| DSRI: 1.04 (Receivables 249.3m/241.8m, Revenue 1.89b/1.90b) |
| GMI: 1.07 (GM 22.96% / 24.64%) |
| AQI: -3.91 (AQ_t -0.50 / AQ_t-1 0.13) |
| SGI: 1.00 (Revenue 1.89b / 1.90b) |
| TATA: -0.04 (NI 109.4m - CFO 230.5m) / TA 2.70b) |
| Beneish M-Score: -5.89 (Cap -4..+1) = AAA |
What is the price of HXL shares?
As of February 09, 2026, the stock is trading at USD 86.00 with a total of 902,516 shares traded.
Over the past week, the price has changed by +5.41%, over one month by +8.33%, over three months by +26.82% and over the past year by +32.12%.
Over the past week, the price has changed by +5.41%, over one month by +8.33%, over three months by +26.82% and over the past year by +32.12%.
Is HXL a buy, sell or hold?
Hexcel has received a consensus analysts rating of 3.20.
Therefor, it is recommend to hold HXL.
- StrongBuy: 3
- Buy: 1
- Hold: 14
- Sell: 1
- StrongSell: 1
What are the forecasts/targets for the HXL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 85.7 | -0.3% |
| Analysts Target Price | 85.7 | -0.3% |
| ValueRay Target Price | 94.1 | 9.4% |
HXL Fundamental Data Overview February 09, 2026
P/E Trailing = 62.7737
P/E Forward = 39.6825
P/S = 3.6148
P/B = 5.2052
P/EG = 1.2621
Revenue TTM = 1.89b USD
EBIT TTM = 172.7m USD
EBITDA TTM = 293.8m USD
Long Term Debt = 993.0m USD (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 993.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 922.0m USD (from netDebt column, last quarter)
Enterprise Value = 7.77b USD (6.85b + Debt 993.0m - CCE 71.0m)
Interest Coverage Ratio = 4.58 (Ebit TTM 172.7m / Interest Expense TTM 37.7m)
EV/FCF = 48.58x (Enterprise Value 7.77b / FCF TTM 159.9m)
FCF Yield = 2.06% (FCF TTM 159.9m / Enterprise Value 7.77b)
FCF Margin = 8.44% (FCF TTM 159.9m / Revenue TTM 1.89b)
Net Margin = 5.78% (Net Income TTM 109.4m / Revenue TTM 1.89b)
Gross Margin = 22.96% ((Revenue TTM 1.89b - Cost of Revenue TTM 1.46b) / Revenue TTM)
Gross Margin QoQ = 24.63% (prev 21.90%)
Tobins Q-Ratio = 2.87 (Enterprise Value 7.77b / Total Assets 2.70b)
Interest Expense / Debt = 1.17% (Interest Expense 11.6m / Debt 993.0m)
Taxrate = 7.94% (4.00m / 50.4m)
NOPAT = 159.0m (EBIT 172.7m * (1 - 7.94%))
Current Ratio = 2.26 (Total Current Assets 730.7m / Total Current Liabilities 322.7m)
Debt / Equity = 0.79 (Debt 993.0m / totalStockholderEquity, last quarter 1.25b)
Debt / EBITDA = 3.14 (Net Debt 922.0m / EBITDA 293.8m)
Debt / FCF = 5.77 (Net Debt 922.0m / FCF TTM 159.9m)
Total Stockholder Equity = 1.48b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.03% (Net Income 109.4m / Total Assets 2.70b)
RoE = 7.41% (Net Income TTM 109.4m / Total Stockholder Equity 1.48b)
RoCE = 6.99% (EBIT 172.7m / Capital Employed (Equity 1.48b + L.T.Debt 993.0m))
RoIC = 6.80% (NOPAT 159.0m / Invested Capital 2.34b)
WACC = 8.72% (E(6.85b)/V(7.84b) * Re(9.83%) + D(993.0m)/V(7.84b) * Rd(1.17%) * (1-Tc(0.08)))
Discount Rate = 9.83% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.11%
[DCF Debug] Terminal Value 78.95% ; FCFF base≈177.1m ; Y1≈218.5m ; Y5≈372.1m
Fair Price DCF = 60.26 (EV 5.48b - Net Debt 922.0m = Equity 4.56b / Shares 75.7m; r=8.72% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 55.95 | EPS CAGR: 25.78% | SUE: 0.80 | # QB: 0
Revenue Correlation: 77.94 | Revenue CAGR: 6.31% | SUE: 0.95 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.43 | Chg30d=-0.053 | Revisions Net=-1 | Analysts=13
EPS current Year (2026-12-31): EPS=2.24 | Chg30d=-0.109 | Revisions Net=-5 | Growth EPS=+27.1% | Growth Revenue=+9.1%
EPS next Year (2027-12-31): EPS=3.08 | Chg30d=-0.292 | Revisions Net=-2 | Growth EPS=+37.5% | Growth Revenue=+10.8%
P/E Forward = 39.6825
P/S = 3.6148
P/B = 5.2052
P/EG = 1.2621
Revenue TTM = 1.89b USD
EBIT TTM = 172.7m USD
EBITDA TTM = 293.8m USD
Long Term Debt = 993.0m USD (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 993.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 922.0m USD (from netDebt column, last quarter)
Enterprise Value = 7.77b USD (6.85b + Debt 993.0m - CCE 71.0m)
Interest Coverage Ratio = 4.58 (Ebit TTM 172.7m / Interest Expense TTM 37.7m)
EV/FCF = 48.58x (Enterprise Value 7.77b / FCF TTM 159.9m)
FCF Yield = 2.06% (FCF TTM 159.9m / Enterprise Value 7.77b)
FCF Margin = 8.44% (FCF TTM 159.9m / Revenue TTM 1.89b)
Net Margin = 5.78% (Net Income TTM 109.4m / Revenue TTM 1.89b)
Gross Margin = 22.96% ((Revenue TTM 1.89b - Cost of Revenue TTM 1.46b) / Revenue TTM)
Gross Margin QoQ = 24.63% (prev 21.90%)
Tobins Q-Ratio = 2.87 (Enterprise Value 7.77b / Total Assets 2.70b)
Interest Expense / Debt = 1.17% (Interest Expense 11.6m / Debt 993.0m)
Taxrate = 7.94% (4.00m / 50.4m)
NOPAT = 159.0m (EBIT 172.7m * (1 - 7.94%))
Current Ratio = 2.26 (Total Current Assets 730.7m / Total Current Liabilities 322.7m)
Debt / Equity = 0.79 (Debt 993.0m / totalStockholderEquity, last quarter 1.25b)
Debt / EBITDA = 3.14 (Net Debt 922.0m / EBITDA 293.8m)
Debt / FCF = 5.77 (Net Debt 922.0m / FCF TTM 159.9m)
Total Stockholder Equity = 1.48b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.03% (Net Income 109.4m / Total Assets 2.70b)
RoE = 7.41% (Net Income TTM 109.4m / Total Stockholder Equity 1.48b)
RoCE = 6.99% (EBIT 172.7m / Capital Employed (Equity 1.48b + L.T.Debt 993.0m))
RoIC = 6.80% (NOPAT 159.0m / Invested Capital 2.34b)
WACC = 8.72% (E(6.85b)/V(7.84b) * Re(9.83%) + D(993.0m)/V(7.84b) * Rd(1.17%) * (1-Tc(0.08)))
Discount Rate = 9.83% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.11%
[DCF Debug] Terminal Value 78.95% ; FCFF base≈177.1m ; Y1≈218.5m ; Y5≈372.1m
Fair Price DCF = 60.26 (EV 5.48b - Net Debt 922.0m = Equity 4.56b / Shares 75.7m; r=8.72% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 55.95 | EPS CAGR: 25.78% | SUE: 0.80 | # QB: 0
Revenue Correlation: 77.94 | Revenue CAGR: 6.31% | SUE: 0.95 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.43 | Chg30d=-0.053 | Revisions Net=-1 | Analysts=13
EPS current Year (2026-12-31): EPS=2.24 | Chg30d=-0.109 | Revisions Net=-5 | Growth EPS=+27.1% | Growth Revenue=+9.1%
EPS next Year (2027-12-31): EPS=3.08 | Chg30d=-0.292 | Revisions Net=-2 | Growth EPS=+37.5% | Growth Revenue=+10.8%